1. Home
  2. GDYN vs SLP Comparison

GDYN vs SLP Comparison

Compare GDYN & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grid Dynamics Holdings Inc.

GDYN

Grid Dynamics Holdings Inc.

HOLD

Current Price

$9.22

Market Cap

727.6M

Sector

Technology

ML Signal

HOLD

Logo Simulations Plus Inc.

SLP

Simulations Plus Inc.

HOLD

Current Price

$18.35

Market Cap

322.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDYN
SLP
Founded
2006
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
727.6M
322.4M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
GDYN
SLP
Price
$9.22
$18.35
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$11.25
$27.25
AVG Volume (30 Days)
943.5K
332.7K
Earning Date
10-30-2025
01-08-2026
Dividend Yield
N/A
N/A
EPS Growth
457.52
N/A
EPS
0.16
N/A
Revenue
$405,955,000.00
$79,179,000.00
Revenue This Year
$19.77
$2.42
Revenue Next Year
$10.24
$7.05
P/E Ratio
$56.87
N/A
Revenue Growth
23.63
13.09
52 Week Low
$7.37
$12.39
52 Week High
$25.50
$37.67

Technical Indicators

Market Signals
Indicator
GDYN
SLP
Relative Strength Index (RSI) 50.37 46.70
Support Level $9.07 $17.74
Resistance Level $9.95 $19.62
Average True Range (ATR) 0.35 0.69
MACD -0.09 -0.16
Stochastic Oscillator 13.16 24.14

Price Performance

Historical Comparison
GDYN
SLP

About GDYN Grid Dynamics Holdings Inc.

Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Share on Social Networks: